Based on these data, we deleted either ATM or the related protein kinase DNA-PKcs/PRKDC from A549 lung adenocarcinoma cell lines using CRISPR/Cas9, and used these cells to examine the mechanism of action of olaparib. The gene discussed is PRKDC; the disease is lung adenocarcinoma.